The primary disease related to GRP94/GP96 is lung cancer; in NSLC, overexpression of HSP90B1 is associated with poor prognosis [54]; for adenocarcinoma, increased levels of GRP94/GP96 is associated with progression [55]. Here, HSP90B1 is linked to lung cancer.